TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)

Paramount Global Revenue

TELCON RF PHARMACEUTICAL. had revenue of 9.98B KRW in the quarter ending March 31, 2025, with 24.23% growth. This brings the company's revenue in the last twelve months to 39.81B, up 7.07% year-over-year. In the year 2024, TELCON RF PHARMACEUTICAL. had annual revenue of 37.87B with 4.29% growth.

• Revenue (ttm): 39.81B
• Revenue Growth: +7.07%
• P/S Ratio: 1.55
• Revenue / Employee: 321.07M
• Employees: 124
• Market Cap: 61.69B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	37.87B	1.56B	4.29%
Dec 31, 2023	36.31B	8.48B	30.46%
Dec 31, 2022	27.83B	-10.01B	-26.46%
Dec 31, 2021	37.84B	4.70B	14.18%
Dec 31, 2020	33.14B	-23.45B	-41.44%